Published in Nature on May 26, 1977
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med (1982) 3.34
Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med (1981) 3.27
Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med (1980) 3.00
Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1987) 1.39
Enhancement of the primary cytotoxic response to membrane by a lymphokine costimulator. Proc Natl Acad Sci U S A (1979) 0.86
Helper T cells for cytotoxic T lymphocytes need not be I region restricted. J Exp Med (1982) 0.84
Multiple pathways of T-T interaction in the generation of cytotoxic T lymphocytes to alloantigens. J Exp Med (1980) 0.79
Biological effects of allogeneic effect factor on T lymphocytes: in vitro induction of cytotoxic T lymphocytes manifesting preferential lytic activity against H-2-identical tumor cells. Proc Natl Acad Sci U S A (1979) 0.77
Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells. Immunology (1979) 0.75
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol (1991) 2.46
Human allograft acceptance is associated with immune regulation. J Clin Invest (2000) 1.94
Isogeneic lymphocyte interaction: recognition of self antigens by cells of the neonatal thymus. Proc Natl Acad Sci U S A (1970) 1.78
The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol (1998) 1.72
Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature (1966) 1.68
Influence of thymosin on cell-mediated and humoral immune responses in normal and in immunologically deficient mice. J Immunol (1970) 1.62
Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization. Dig Dis Sci (1979) 1.60
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol (1992) 1.34
Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. J Immunol (1983) 1.25
Splenic determination of immunocompetence: influence on other lymphoid organs. Cell Immunol (1971) 1.23
Adult murine lymph node cells respond blastogenically to a new differentiation antigen on isologous and autologous B lymphocytes. J Immunol (1975) 1.22
Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. J Immunol (2001) 1.22
Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines. J Immunol (1985) 1.19
Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen. J Immunol (1983) 1.15
A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation (1998) 1.13
Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. J Immunol (1983) 1.12
Can graft endothelial cells initiate a host anti-graft immune response? Transplantation (1996) 1.12
Mechanism of immunologic unresponsiveness: a new approach. Fed Proc (1990) 1.12
Immunoglobulin synthesis in hereditarily spleenless mice. Nature (1969) 1.12
Inflammation-induced endothelial cell adhesion to lymphocytes, neutrophils, and monocytes. Role of homing receptors and other adhesion molecules. Transplantation (1989) 1.11
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res (1999) 1.09
Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum Immunol (1999) 1.09
Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J Biol Chem (1990) 1.09
Spontaneous delayed iso-hypersensitivity in guinea pigs. J Immunol (1968) 1.08
Analysis of cloned T cell function. II. Differential blockade of various cloned T cell functions by cyclosporine. Transplantation (1983) 1.08
Regulation of immunoglobulin synthesis by dextran. J Exp Med (1973) 1.07
Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation (1997) 1.07
Immunologic responses of guinea pigs to dextran. J Immunol (1968) 1.07
Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J Immunol (1985) 1.06
Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol Rev (2000) 1.06
Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection. Transplantation (1999) 1.06
Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides. Dig Dis Sci (1981) 1.03
T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation (1992) 1.03
Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration. Transplantation (1989) 1.03
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest (1999) 1.02
Detection of HSV-1-induced lymphokine production in human cells by a direct indicator cell addition assay. J Immunol (1984) 0.99
Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals. J Clin Microbiol (1989) 0.98
Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts. Transplantation (1993) 0.98
Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation (1998) 0.97
Placental mononuclear phagocytes as a source of interleukin-1. Science (1982) 0.97
Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol (2001) 0.97
Splenic replenishment of synergistic ability to bone marrow and thymic cells of neonatally splenectomized CBA mice. J Exp Med (1972) 0.97
Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function. Reg Immunol (1990) 0.97
Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. Cancer Res (1991) 0.95
In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts. Transplantation (1986) 0.95
In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation (1998) 0.95
Susceptibility to adjuvant arthritis in DA and F344 rats. A dominant trait controlled by an autosomal gene locus linked to the major histocompatibility complex. Arthritis Rheum (1982) 0.95
Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays. J Immunol (1983) 0.94
Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice. Transplantation (2000) 0.94
Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation (1997) 0.94
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst (1999) 0.94
HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant (1994) 0.94
Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res (1999) 0.93
Specific immunologic unresponsiveness induced in adult guinea pigs with the aid of p-azobenzenearsonate hapten coupled to autologous red cells. J Immunol (1971) 0.93
Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts. Transplantation (1993) 0.92
Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A. J Immunol (1982) 0.92
Caspase-dependent and -independent death pathways in cancer therapy. Apoptosis (2000) 0.92
Alloantigen-activated CML suppression independent of cytotoxic activity. J Immunol (1979) 0.90
Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation (2000) 0.90
Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population. Cell Immunol (1990) 0.90
Impaired delayed hypersensitivity in germ-free guinea-pigs. Immunology (1970) 0.90
Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes. Apoptosis (2001) 0.90
Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection. Am J Transplant (2006) 0.90
In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation (1993) 0.89
Disruption of murine cardiac allograft acceptance by latent cytomegalovirus. Am J Transplant (2008) 0.89
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. Clin Cancer Res (1998) 0.88
A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen. Transplantation (2001) 0.88
Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma. J Immunother (1997) 0.88
Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation (1996) 0.88
Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection. Am J Pathol (1995) 0.87
Specificity of fixation loci for homocytotropic antibodies. J Exp Med (1971) 0.87
Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations. Transplantation (1996) 0.87
Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene (2012) 0.86
Size of the donor-reactive CTL pool determined by limiting dilution analysis in sponge matrix allografts. Transplantation (1986) 0.86
Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells. J Immunol (1992) 0.86
Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes. J Immunol (1981) 0.86
IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages. J Immunol (1992) 0.86
Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression. Transplantation (1994) 0.86
The role of vascular endothelial cells in transplantation. Arch Pathol Lab Med (1991) 0.86
Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion. J Immunol (1985) 0.86
Adoptive cutaneous anaphylaxis: a technique for studying antibody globulin synthesis. J Immunol (1966) 0.86
Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis. Hum Immunol (2000) 0.86
Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2. J Immunol (1985) 0.85
Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice. Hepatology (2000) 0.85
Responses against single minor histocompatibility antigens. II. Analysis of cloned helper T cells. J Immunol (1984) 0.85
Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation (1997) 0.85
Soluble helper factor(s) participates in the generation of cell mediated cytotoxicity directed against syngeneic tumor cells. J Immunol (1979) 0.85
In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles. Inhal Toxicol (2013) 0.84
T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance. Crit Rev Immunol (2001) 0.84
Suppression of adjuvant arthritis by antibodies specific for collagen type II. Immunol Commun (1981) 0.84
Morphometric analysis of neointimal formation in murine cardiac grafts: III. Dissociation of intestitial fibrosis from neointimal formation. Transplantation (1997) 0.84
Morphometric analysis of neointimal formation in murine cardiac allografts: II. Rate and location of lesion development. Transplantation (1997) 0.84
Mechanisms of graft acceptance: evidence that plasminogen activator controls donor-reactive delayed-type hypersensitivity responses in cardiac allograft acceptor mice. J Immunol (2000) 0.84
Use of immunotolerance to dissect the mechanisms regulating appearance of hapten-specific killer T cells in vivo. J Immunol (1980) 0.84
Apoptosis in murine cardiac grafts. Transplantation (1997) 0.84
Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape. Cancer J Sci Am (2000) 0.84
In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor. J Immunol (1983) 0.84